 Eligible patients will enter into the pharmacokinetics part of the study at Visit 2 where blood samples will be taken using a sparse sampling strategy to minimize the blood volumes required for analysis of the plasma concentrationtime curve for concomitant AEDs and routine safety bloods. This is conducted prior to the administration of Study medication at Dose Level 1. 